A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
2,5-Dimethoxyamphetamine
Phenprobamate
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Phenprobamate.
2,5-Dimethoxyamphetamine
Deanol
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Deanol.
2,5-Dimethoxyamphetamine
Pinazepam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Pinazepam.
2,5-Dimethoxyamphetamine
Pyrithyldione
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Pyrithyldione.
2,5-Dimethoxyamphetamine
Tetrazepam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Tetrazepam.
2,5-Dimethoxyamphetamine
Trichloroethylene
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Trichloroethylene.
2,5-Dimethoxyamphetamine
Febarbamate
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Febarbamate.
2,5-Dimethoxyamphetamine
Atracurium
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Atracurium.
2,5-Dimethoxyamphetamine
Sultopride
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Sultopride.
2,5-Dimethoxyamphetamine
Clothiapine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Clothiapine.
2,5-Dimethoxyamphetamine
Proxibarbal
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Proxibarbal.
2,5-Dimethoxyamphetamine
Propanidid
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Propanidid.
2,5-Dimethoxyamphetamine
Apronalide
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Apronalide.
2,5-Dimethoxyamphetamine
Medifoxamine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Medifoxamine.
2,5-Dimethoxyamphetamine
Butaperazine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Butaperazine.
2,5-Dimethoxyamphetamine
Valnoctamide
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Valnoctamide.
2,5-Dimethoxyamphetamine
Nefiracetam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Nefiracetam.
2,5-Dimethoxyamphetamine
Tiapride
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Tiapride.
2,5-Dimethoxyamphetamine
Hypericin
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Hypericin.
2,5-Dimethoxyamphetamine
Neosaxitoxin
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Neosaxitoxin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3